Table 2 Sub-distribution hazard ratios for the competing risks of ESRD and mortality based on a Fine-Gray model
Mortality prior to ESRD | ESRD | |||||
|---|---|---|---|---|---|---|
Sub-HR | 95% CI | p-value | Sub-HR | 95% CI | p-value | |
Age | 1.06 | 1.04–1.08 | < 0.01 | 0.97 | 0.95–0.98 | < 0.01 |
Male | 1.23 | 0.72–2.14 | 0.46 | 1.49 | 1.03–2.16 | 0.03 |
SBP | 1.01 | 0.99–1.02 | 0.43 | 1.01 | 1.00–1.02 | 0.09 |
DBP | 0.99 | 0.96–1.01 | 0.30 | 1.01 | 0.99–1.02 | 0.43 |
Hypertension | 1.27 | 0.30–5.45 | 0.75 | 0.68 | 0.36–1.30 | 0.24 |
Diabetes | 1.36 | 0.78–2.36 | 0.28 | 0.63 | 0.41–0.98 | 0.04 |
Smoking | 1.46 | 0.82–2.59 | 0.20 | 0.89 | 0.62–1.29 | 0.55 |
MI | 2.49 | 1.35–4.61 | 0.04 | 0.36 | 0.11–1.15 | 0.08 |
CCF | 1.08 | 0.58–2.00 | 0.81 | 0.80 | 0.35–1.83 | 0.60 |
Stroke | 1.00 | 0.38–2.64 | 0.99 | 0.67 | 0.30–1.52 | 0.34 |
PVD | 1.22 | 0.63–2.33 | 0.56 | 0.98 | 0.53–1.83 | 0.95 |
ACEi/ARB | 0.63 | 0.39–1.01 | 0.06 | 1.06 | 0.71–1.58 | 0.77 |
Statin | 0.79 | 0.45–1.37 | 0.40 | 1.32 | 0.92–1.91 | 0.13 |
eGFR | 1.01 | 0.98–1.03 | 0.48 | 0.96 | 0.94–0.97 | < 0.01 |
Bicarbonate | 1.00 | 0.94–1.07 | 0.89 | 1.02 | 0.97–1.08 | 0.49 |
Calcium | 0.92 | 0.22–3.87 | 0.91 | 0.48 | 0.15–1.48 | 0.20 |
Phosphate | 0.38 | 0.10–1.42 | 0.15 | 3.15 | 1.29–7.67 | 0.01 |
Albumin | 1.00 | 0.95–1.05 | 0.83 | 0.99 | 0.95–1.02 | 0.43 |
Haemoglobin | 0.97 | 0.95–0.99 | 0.02 | 1.00 | 0.99–1.01 | 0.86 |
A3 proteinuria | 0.58 | 0.34–1.00 | 0.05 | 1.00 | 0.71–1.42 | 0.99 |